PRECISION BIOSCIENCES INC cotiza a 6.10 USD y tiene una capitalización bursátil de $168M. En los últimos 12 meses ha facturado $45M con un margen de flujo de caja libre del -192.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-1.26 | $-0.75 | $1.01 |
| Estimado | $-0.89 | $-0.69 | $-0.81 | $-0.64 |
| Sorpresa | — | -82.6% | +7.4% | +257.8% |
| Métrica | DTIL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -152.2% | -38.6% | -113.6% |
| Net Margin | -133.4% | -33.6% | -99.9% |
| FCF Margin | -192.4% | -13.9% | -178.6% |
| ROE | -49.6% | -40.4% | -9.2% |
| ROA | -29.6% | -32.0% | +2.4% |
| Current Ratio | 13.32 | 2.84 | +10.48 |
| Debt / Equity | — | 0.28 | — |